Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Wegovy continues escalating) Months 46 (Wegovy only): 1.7 mg 2.4 mg weekly maintenance dose Clinical data from the STEP 5 trial (2-year follow-up) showed that the majority of participants tolerated semaglutide well in the long term, with fewer than 4% discontinuing due to side effects
Figure 3 Semaglutide prevents high-fat diet-induced endothelial cell ultrastructural changes Aortic endothelial cell were elongated and tightly adhered to the internal elastic lamina in NCD group
Nearly half of surveyed payers plan to differentiate the PA process for GLP-1s based on indication, by excluding coverage for obesity and allowing restricted coverage for comorbidities
Preference for pharmaceutical formulation and treatment process attributes
US$ 27.17
US$ 26.00
US$ 29.50
US$ 26.74
US$ 23.39
US$ 24.24
US$ 28.45
